David M. Knott Jr’s Inozyme Pharma INZY Stock Holding History

David M. Knott Jr’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-666,204	Closed	-$2.66M	–	94
2025 Q2	$2.66M	Hold	666,204	–	–	1.21%	16
2025 Q1	$606K	Sell	666,204 -28,796	-4%	-$39.9K	0.29%	43
2024 Q4	$1.93M	Buy	695,000 +130,451	+23%	+$496K	0.7%	22
2024 Q3	$2.95M	Hold	564,549	–	–	1.04%	20
2024 Q2	$2.52M	Hold	564,549	–	–	1%	19
2024 Q1	$4.32M	Hold	564,549	–	–	1.53%	16
2023 Q4	$2.4M	Buy	564,549 +110,541	+24%	+$393K	0.92%	19
2023 Q3	$1.91M	Buy	454,008 +234,008	+106%	+$1.19M	0.73%	29
2023 Q2	$1.23M	Buy	220,000 +60,000	+38%	+$355K	0.49%	35
2023 Q1	$917K	Buy	+160,000	New	+$423K	0.36%	43

David M. Knott Jr's INZY Position: Q3 2025 in Review

David M. Knott Jr sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 666,204 shares — an estimated $2.66M sold.

David M. Knott Jr first reported a position in INZY in Q1 2023 and held it in 10 quarters. The position peaked at $4.32M in Q1 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

David M. Knott Jr reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
David M. Knott Jr sold 666,204 Inozyme Pharma shares in Q3 2025, an estimated $2.66M.
David M. Knott Jr first reported a position in Inozyme Pharma in Q1 2023 and held it in 10 quarters.
David M. Knott Jr's Inozyme Pharma position peaked at $4.32M in Q1 2024.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on David M. Knott Jr's 13F filing for Q3 2025, filed 12 Nov 2025.